Back To: Home : Featured Technology : Reagents/Proteins

CLICK HERE FOR WHAT'S NEW IN:
 
 
 

Caprion wins NIAID biomarker research contract
November 2008
SHARING OPTIONS:

MONTREAL—Caprion Proteomics has won a $12.9 million contract from the National Institute of Allergy and Infectious Diseases (NIAID) to research biomarkers for infectious diseases. Under the five-year contract, Caprion will act as one of two NIAID Clinical Proteomics Centers for Infectious Disease and Biodefense, and it will use its CellCarta protein profiling technology to conduct large-scale applied proteomics projects on human clinical samples. The studies Caprion will conduct will focus on discovering, qualifying and verifying candidate biomarkers that can be used to detect, diagnose and monitor responses to therapeutics and vaccines and disease susceptibility.

Caprion is still engaged in a previous contract from NIAID, awarded in 2004, under which it is focused on identifying new immunotherapy targets, vaccines and diagnostic candidates that are based on host and pathogen proteins involved in Brucella infections.

 

Back


PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.